New Therapeutic Perspectives in Type B Insulin Resistance Syndrome: Efficacy of a Multitarget Therapy With Obinutuzumab and Mycophenolate Mofetil in Two Patients With Insulin Receptor Autoantibodies and Systemic Lupus Erythematosus

Diabetes Care. 2025 Jan 29:dc242203. doi: 10.2337/dc24-2203. Online ahead of print.
No abstract available

Publication types

  • Letter